Skip to navigation Skip to main content

Your search for bevacizumab returned 150 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for bevacizumab returned 150 results

Sort Results:

Relevant Recent
News

ASCO: Continuing Avastin With 2nd-Line Chemo Ups Survival

Publish Date
Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC) who have progressed after discontinuation of first-line bevacizumab and chemotherapy.
News

Tecentriq Combination Regimen Approved for Metastatic Non-Squamous NSCLC

Publish Date
The approval was based on data from the IMpower 150 trial, an open-label study involving 1202 patients with stage IV metastatic NSq NSCLC who had not received prior chemotherapy for metastatic disease, but could have received prior EGFR or ALK kinase inhibitor if appropriate, regardless of PD-L1 or T-effector gene status and ECOG performance status 0 or 1.
ASCO 2011

ICON7 Trial Shows Bevacizumab Increases Survival in Women with Newly Diagnosed Ovarian Cancer

Publish Date
The addition of bevacizumab to carboplatin and paclitaxel chemotherapy for the first-line treatment of women with ovarian cancer may offer benefit compared with standard chemotherapy alone, particularly for patients with more aggressive disease, investigators noted in a presentation during the American Society of Clinical Oncology's 2011 Annual Meeting.